Uniqure NV UQ1-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 3:45 PM CEST
25.43quote price arrow down-0.79 (-3.01%)
Volume
30
52 week range
24.40 - 61.44

...

Loading . . .
  • Open25.43
  • Day High26.61
  • Day Low25.43
  • Prev Close26.61
  • 52 Week High61.44
  • 52 Week High Date06/23/20
  • 52 Week Low24.40
  • 52 Week Low Date03/29/21

Key Stats

  • Market Cap1,445.24M
  • Shares Out44.78M
  • 10 Day Average Volume96.9
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-13.39

KEY STATS

  • Open25.43
  • Day High26.61
  • Day Low25.43
  • Prev Close26.61
  • 52 Week High61.44
  • 52 Week High Date06/23/20
  • 52 Week Low24.40
  • 52 Week Low Date03/29/21
  • Market Cap1,445.24M
  • Shares Out44.78M
  • 10 Day Average Volume96.9
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-13.39

RATIOS/PROFITABILITY

  • EPS (TTM)-2.31
  • P/E (TTM)-11.01
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Uniqure NV

There is no recent news for this security.

Profile

MORE
Uniqure NV is a company based in the Netherlands specialized in gene therapy. It seeks to develop one-time administered treatments with potentially curative results for patients suffering from genetic and other devastating diseases. It develops, both internally and through partnerships, a pipeline of gene therapies. It produces adeno-associated virus based, or AAV-based, gene therapies in its own facilities with a proprietary, commercial-scale, current good manufacturing...
Philip Astley-Sparke
Non-Executive Chairman
Matthew Kapusta CPA
Chief Executive Officer
Ricardo Dolmetsch
President
Alexander Kuta Ph.D., III
Executive Vice President
Address
Paasheuvelweg 25a
Amsterdam
1105 BP
Netherlands